-+ 0.00%
-+ 0.00%
-+ 0.00%

Seaport Therapeutics Q3 EPS $(0.49) Beats $(0.58) Estimate

Benzinga·11/02/2026 12:07:17
Listen to the news
Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.58) by 15.52 percent. This is a 94.8 percent increase over losses of $(9.43) per share from the same period last year.